Simple IV drip may prevent painful complication after common bile duct procedure
NCT ID NCT06260878
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a short course of intravenous Ringer's lactate fluid around the time of an ERCP procedure can prevent pancreatitis, a common and serious side effect. Researchers will enroll 505 adults aged 18-75 who are having their first ERCP. Participants will receive the IV fluid and be monitored for signs of pancreatitis the next day.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Intravenous Ringer's lactate
What this could lead to
If successful, this could provide a simple, low-cost way to prevent a common and serious complication of ERCP, reducing hospital stays and improving patient outcomes.
What could go wrong
This is a single-center trial with 505 participants, so results may not apply to all patients. The benefit may be small or absent, and there is a risk of fluid overload in some individuals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peter Lougheed Centre
RECRUITINGCalgary, Alberta, T1Y 6J4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••